> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Sets Policy on Scoring of Generic Drug Tablets
- URL: https://www.fdaweb.com/fda-sets-policy-on-scoring-of-generic-drug-tablets/
- Published: 2016-03-08T12:00:00.000Z
- Updated: 2026-09-15T02:41:50.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5134994

> The CDER Office of Generic Drugs has issued a Manual of Policies and Procedures (MAPP) on scoring configuration of generic drug products. The [document](http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM079779.pdf?ref=fdaweb.com) says that consistent scoring assures that patients are able to adjust the drug’s dose by breaking a generic drug in the same manner as the branded product. Consistent scoring also assures that neither the generic product nor the listed drug may have a marketplace advantage due to the score.  
>  
> The MAPP says that the scoring configuration of a generic tablet should be the same as that of the listed drug and should be evident in the exhibit batch when the application is submitted to the agency.  
>  
> If the scoring configuration of the exhibit batch does not match that of the listed drug, it says, the generic firm will be requested to provide a commitment not to market the product until it is correctly scored.  
>  
> The MAPP also includes special considerations such as changes in listed drug scoring and patented scoring configuration.